Radiographic Bone Evaluation After Periodontal Full Mouth Disinfection Treatment In Women Undergoing Chemotherapy Or Hormone Therapy With Tamoxifen

dc.creatorFreire de Assis
dc.creatorRahyza Inacio; Silva-Junior
dc.creatorManoelito Ferreira; dos Santos
dc.creatorMarciel Silva; Rangel Pereira
dc.creatorTeresa Cristina; Rodrigues Feitosa
dc.creatorAlfredo Carlos; de Azevedo-Vaz
dc.creatorSergio Lins
dc.date2016
dc.date2017-11-13T13:22:05Z
dc.date2017-11-13T13:22:05Z
dc.date.accessioned2018-03-29T05:54:55Z
dc.date.available2018-03-29T05:54:55Z
dc.identifierPesquisa Brasileira Em Odontopediatria E Clinica Integrada. Assoc Apoio Pesquisa & Saude Bucal-apesb, v. 16, p. 219 - 227, 2016.
dc.identifier1519-0501
dc.identifier1983-4632
dc.identifierWOS:000382866300017
dc.identifier10.4034/PBOCI.2016.161.23
dc.identifierhttp://revista.uepb.edu.br/index.php/pboci/article/view/2663
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/327819
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1364844
dc.descriptionTo radiographically evaluate the alveolar bone level after periodontal full mouth disinfection (FMD) treatment in women during chemotherapy (CHE) and hormone therapy with Tamoxifen (TAM). Material and Methods: This is an uncontrolled clinical trial with a convenience sample of women in antineoplastic treatment (CHE and TAM) and non-surgical periodontal FMD treatment. The Radiographic examination consisted of four bitewing radiographs and six periapical radiographs of the upper and lower anterior teeth, acquired according to the parallelling standard technique at three times: before (T0), 3 (T3) and 6 (T6) months after periodontal treatment. The alveolar crest level in the interproximal area of each tooth was measured by two calibrated observer using magnifying glass and digital caliper. Statistical analysis was performed for evaluation of the three times in each experimental group using the Friedman test (p < 0.05) and between groups, the Mann Whitney test (p < 0.05). Results: Overall, 14 women undergoing treatment for breast cancer participated in this study. A follow-up loss of five (35.71%) women occurred during the study and the final sample size was composed of nine women divided into two groups: CHE (n = 4) and TAM (n = 5). A total of 330 sites were evaluated: 126 (CHE) and 204 (TAM). The alveolar bone level showed statistically significant reduction after 6 months of FMD therapy (p < 0.05), but there was no difference between antineoplastic treatment type (p> 0.05). Conclusion: Patients undergoing chemotherapy and hormone therapy with Tamoxifen showed better alveolar bone levels after six months of periodontal FMD treatment. The current antineoplasic therapy did not influence the results obtained with periodontal treatment.
dc.description16
dc.description1
dc.description219
dc.description227
dc.languageEnglish
dc.publisherAssoc Apoio Pesquisa & Saude Bucal-Apesb
dc.publisherJoão Pessoa
dc.relationPesquisa Brasileira em Odontopediatria e Clinica Integrada
dc.rightsaberto
dc.sourceWOS
dc.subjectBreast Cancer
dc.subjectChemotherapy
dc.subjectTamoxifen
dc.subjectDental Radiography
dc.titleRadiographic Bone Evaluation After Periodontal Full Mouth Disinfection Treatment In Women Undergoing Chemotherapy Or Hormone Therapy With Tamoxifen
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución